Reducing cardiovascular risks in young people with kidney disease
Cardiovascular risk reduction in adolescents and young adults with kidney disease
This study is looking at how kidney disease affects heart health in teens and young adults, especially focusing on high blood pressure, and it offers a chance for patients to help improve care for themselves and others.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10984341 on NIH RePORTER |
What this research studies
This research focuses on understanding and improving cardiovascular health in adolescents and young adults who have kidney disease. It aims to investigate hypertension and cardiovascular outcomes, particularly how these conditions affect young patients. The study will utilize a variety of datasets and electronic health records to analyze health disparities and develop effective interventions. Patients may have the opportunity to participate in clinical assessments and contribute to research that could lead to better health management strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults diagnosed with kidney disease, particularly those experiencing hypertension.
Not a fit: Patients without kidney disease or those who are not within the adolescent to young adult age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cardiovascular health and management strategies for young patients with kidney disease.
How similar studies have performed: Previous research has shown promising results in addressing cardiovascular risks in patients with kidney disease, indicating that this approach has potential for success.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Ku, Elaine — University of California, San Francisco
- Study coordinator: Ku, Elaine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.